Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat
Open Access
- 1 May 1999
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 64 (5), 1371-1377
- https://doi.org/10.1086/302366
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen ReceptorJNCI Journal of the National Cancer Institute, 1997
- BRCA1 expression is not directly responsive to estrogenOncogene, 1997
- Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroidsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Risk modifiers in carriers of brca1 mutationsInternational Journal of Cancer, 1995
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Androgens induce divergent proliferative responses in human breast cancer cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathiesHuman Molecular Genetics, 1995
- Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophyNature, 1991
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989